The Food and Drug Administration has approved an additional claim for EXCEDE (ceftiofur crystalline free acid) Sterile Suspension from Pfizer Animal Health for the control of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumonia, Pasteurella multocida, Haemophilus parasuis and Streptococcus suis.
“This new claim is another milestone in our commitment to veterinarians to provide tools to better control disease,” says Michael Senn, DVM, manager, veterinary operations for Pfizer Animal Health. “Many pork operations fight SRD pathogens on an ongoing basis. EXCEDE has provided successful treatment to sick pigs and now can be used to control disease in herds with an SRD diagnosis.”
EXCEDE delivers at least seven days of therapeutic plasma levels with a single dose. “This means it starts working right away and continues to provide therapy for an extended period,” says Senn.
EXCEDE is also indicated for the treatment of SRD associated with Actinobacillus pleuropneumonia, Pasteurella multocida, Haemophilus parasuis and Streptococcus suis. The product requires a low-volume dose and comes in 100-ml. size.
EXCEDE should not be given to swine known to be hypersensitive to cephalosporins or penicillins. Following label use as a single treatment, observe a 14-day pre-slaughter period.
Discuss treatment with EXCEDE with your veterinarian or local Pfizer Animal Health representative or visit www.PfizerAH.com.